Chronic myeloid leukemia (CML) is a myeloproliferative disorder driven by the formation of the BCR-ABL fusion gene, which arises from a reciprocal translocation between chromosomes 9 and 22, commonly referred to as the Philadelphia chromosome. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.